Mindray Medical International (MR) Tops Q4 EPS by 3c, Offers FY12 Guidance
Tweet
Share
E-mailGet Alerts MR Hot Sheet
Join SI Premium – FREE
Mindray Medical International (NYSE: MR) reported Q4 EPS of $0.44, $0.03 better than the analyst estimate of $0.41. Revenue for the quarter came in at $264.1 million versus the consensus estimate of $249.17 million.
The company expects its full year 2012 net revenues to grow at least 18% over its full year 2011 net revenues. The company also expects its full year 2012 non-GAAP net income to grow at least 13% over its non-GAAP net income for full year 2011.
For earnings history and earnings-related data on Mindray Medical International (MR) click here.
The company expects its full year 2012 net revenues to grow at least 18% over its full year 2011 net revenues. The company also expects its full year 2012 non-GAAP net income to grow at least 13% over its non-GAAP net income for full year 2011.
For earnings history and earnings-related data on Mindray Medical International (MR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- FGI Industries Ltd (FGI) Tops Q2 EPS by 59c
- Mannatech (MTEX) Tops Q2 EPS by 53c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
